company background image
CL logo

Colgate-Palmolive NYSE:CL Rapporto sulle azioni

Ultimo prezzo

US$103.95

Cap. di mercato

US$84.5b

7D

2.5%

1Y

41.8%

Aggiornato

22 Aug, 2024

Dati

Dati finanziari dell'azienda +

Colgate-Palmolive Company

NYSE:CL Rapporto sulle azioni

Cap. di mercato: US$84.5b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

CL Panoramica delle azioni

Colgate-Palmolive Company, insieme alle sue controllate, produce e vende prodotti di consumo negli Stati Uniti e a livello internazionale.

CL analisi fondamentale
Punteggio fiocco di neve
Valutazione4/6
Crescita futura2/6
Prestazioni passate4/6
Salute finanziaria4/6
Dividendi5/6

Community Narratives

Narratives bring a range of perspectives from our community.

US$100.30
FV
3.6% overvalued intrinsic discount
3.87%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
30 days agoauthor updated this narrative

Colgate-Palmolive Company Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Colgate-Palmolive
Prezzi storici delle azioni
Prezzo attuale dell'azioneUS$103.95
Massimo di 52 settimaneUS$104.15
Minimo di 52 settimaneUS$67.62
Beta0.39
1Variazione di 1 mese7.66%
Variazione a 3 mesi11.41%
Variazione di 1 anno41.78%
3Variazione a 3 anni34.46%
Variazione a 5 anni40.09%
Variazione dall'IPO11,144.17%

Notizie e aggiornamenti recenti

Colgate-Palmolive: Stability Pillar Reached Its Fair Value

Aug 19

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Aug 12
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Colgate-Palmolive: Good Growth Prospects Ahead

Aug 06

Recent updates

Colgate-Palmolive: Stability Pillar Reached Its Fair Value

Aug 19

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Aug 12
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued

Colgate-Palmolive: Good Growth Prospects Ahead

Aug 06

Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)

Jul 11
Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)

Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings

Jul 10

Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite

Jun 23

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Jun 06
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital

May 21
Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital

Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Apr 30
Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report

Colgate-Palmolive: Loading Up Ahead Of Earnings

Apr 16

Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E

Apr 02
Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E

Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 18
Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year

Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?

Feb 14
Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?

Colgate-Palmolive: I'm Buying Before Interest Rates Decrease

Feb 14

Colgate-Palmolive: Brushing Up Profits In Q4 2023

Jan 30

Is Colgate-Palmolive (NYSE:CL) A Risky Investment?

Jan 19
Is Colgate-Palmolive (NYSE:CL) A Risky Investment?

Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult

Jan 01
Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult

Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)

Dec 20

Colgate-Palmolive Stock And Its Real Value

Nov 29

Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On

Nov 14

Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends

Nov 06
Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends

Colgate-Palmolive: Own This Dividend King At The Right Price

Oct 31

Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now

Oct 13

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Oct 02
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Colgate-Palmolive: Dividend King With Limited Growth

Sep 27

An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued

Sep 11
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued

Colgate-Palmolive: Improving Prospects And A Reasonable Valuation

Sep 09

Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World

Aug 16

Colgate And The Importance Of Sales Growth, Expectations Matter

Aug 09

Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Aug 03
Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business

Colgate-Palmolive: Challenging Growth Prospects

Jul 10

Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48

Jun 27
Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48

Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48

Jun 13
Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48

Colgate-Palmolive: The Reasons We Are Becoming More Cautious

Jun 05

Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly

Jun 05
Here's Why Colgate-Palmolive (NYSE:CL) Can Manage Its Debt Responsibly

Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)

May 18
Calculating The Intrinsic Value Of Colgate-Palmolive Company (NYSE:CL)

Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Feb 23
Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)

Feb 05
Calculating The Fair Value Of Colgate-Palmolive Company (NYSE:CL)

What to expect from Colgate-Palmolive's Q4 2022 Earnings

Jan 26

Rendimenti per gli azionisti

CLUS Household ProductsUS Mercato
7D2.5%1.2%3.1%
1Y41.8%10.6%24.9%

Ritorno vs Industria: CL ha superato il US Household Products che ha restituito 10.5 % nell'ultimo anno.

Rendimento vs Mercato: CL ha superato il mercato US che ha restituito 25.6 % nell'ultimo anno.

Volatilità dei prezzi

Is CL's price volatile compared to industry and market?
CL volatility
CL Average Weekly Movement2.3%
Household Products Industry Average Movement3.3%
Market Average Movement6.3%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market3.2%

Prezzo delle azioni stabile: CL non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 2% ) di CL è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
180634,000Noel Wallacewww.colgatepalmolive.com

Colgate-Palmolive Company, insieme alle sue controllate, produce e vende prodotti di consumo negli Stati Uniti e a livello internazionale. Opera attraverso due segmenti: Oral, Personal and Home Care e Pet Nutrition. Il segmento Oral, Personal and Home Care offre dentifrici, spazzolini da denti, collutori, saponi per le mani in barrette e liquidi, gel doccia, shampoo, balsami, deodoranti e antitraspiranti, prodotti per la salute della pelle, detersivi per piatti, ammorbidenti, detergenti per la casa e altri prodotti correlati.

Colgate-Palmolive Company Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Colgate-Palmolive con la sua capitalizzazione di mercato?
CL statistiche fondamentali
Capitalizzazione di mercatoUS$84.54b
Guadagni(TTM)US$2.84b
Ricavi(TTM)US$19.99b

29.9x

Rapporto P/E

4.2x

Rapporto P/S

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
CL Conto economico (TTM)
RicaviUS$19.99b
Costo del fatturatoUS$8.06b
Profitto lordoUS$11.93b
Altre speseUS$9.09b
GuadagniUS$2.84b

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)3.48
Margine lordo59.70%
Margine di profitto netto14.21%
Rapporto debito/patrimonio netto1,800.0%

Come si è comportato CL nel lungo periodo?

Vedi performance storica e confronto

Dividendi

1.9%

Rendimento attuale del dividendo

56%

Rapporto di remunerazione